obeticholic acid: from pk model to drug label
Published 7 years ago • 11K plays • Length 50:00Download video MP4
Download video MP3
Similar videos
-
57:02
how to optimize your drug label using biosimulation methodology
-
18:14
using pop pk modeling to optimize dosing in patients with organ impairment
-
40:57
precision dosing using pbpk modeling
-
1:13:05
pbpk modelling to predict salt form advantage when dosed with acid-reducing agents
-
55:39
a best practice framework for applying pbpk modeling to pediatric drug development
-
1:01:14
pbpk modeling & simulation to support asciminib nda submission and inform drug product label
-
10:21
ph value, poh value and acid base indicators
-
39:31
mechanistic and conventional ivivc: complementary or clashing approaches?
-
47:14
pml school: minimal physiologically-based pharmacokinetic model for monoclonal antibodies (mabs)
-
49:40
pbpk modeling and simulation: bridging the “bottom up” and “top-down” approaches
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
59:17
applications of pbpk modelling for regulatory submissions: case studies
-
58:36
pbpk for the pill an approach to assess the risk benefit of drugs
-
5:15
24. dosing simulations using addl